Margins
← Earnings Calls
01
02
03
04 05 06
Tone
Capex
A1 A2 A3 A4
IFF
FY2026 Q1
In line
International Flavors & Fragrances, Inc. earnings call
Buzzberg read
Q1 EBITDA margin highest since Q2 2022
IFF reported a strong Q1 2026 with better-than-expected volume growth and margin expansion, but management maintained full-year guidance, citing significant inflation and Middle East conflict-related headwinds expected to impact Q2 and the rest of the year. Strong Q1: Revenue of >$2.7B (+3% CC) and Adjusted EBITDA of $568M (+8% CC) beat internal expectations, driven by volume across all segments.
Buzzberg read Q1 EBITDA margin highest since Q2 2022 IFF reported a strong Q1 2026 with better-than-expected volume growth and margin expansion, but management maintained full-year guidance, citing significant inflation and Middle East conflict-related headwinds expected to impact Q2 and the rest of the year. Strong Q1: Revenue of >$2.7B (+3% CC) and Adjusted EBITDA of $568M (+8% CC) beat internal expectations, driven by volume across all segments. Read full analysisCollapse analysis
IFF reported a strong Q1 2026 with better-than-expected volume growth and margin expansion, but management maintained full-year guidance, citing significant inflation and Middle East conflict-related headwinds expected to impact Q2 and the rest of the year. Strong Q1: Revenue of >$2.7B (+3% CC) and Adjusted EBITDA of $568M (+8% CC) beat internal expectations, driven by volume across all segments.
- Full-year guidance maintained at $10.5B-$10.8B revenue and $2.05B-$2.15B EBITDA, despite a stronger Q1, due to a more cautious outlook for Q2.
- Q2 EBITDA expected to be lower than Q1 due to Middle East conflict impacting fine fragrance demand, inflation starting to hit, and pricing surcharges not yet fully implemented.
- Divestiture of commodity soy business to Bungie closed in March; sale process for food ingredients is advanced with an update expected by Q2 call.
Revenue$2.741B+6% QoQ
EPS$1.25+56% QoQ
Gross margin37.14%Reported
Operating margin10.18%Reported
6 grounded callouts
What matters now
The highest-signal changes from the call.
Portfolio
Food ingredients divestiture progressing with multiple buyers
Guidance
Q2 EBITDA expected lower due to Middle East conflict
Show 3 more callouts
Pricing
Pricing surcharges to offset inflation, but lag in Q2
Product Strategy
De-emphasizing commodity fragrance ingredients sales
Cash Flow
Working capital and cash flow improvement key focus
Reported period
Actuals
| Metric | Reported | Change |
|---|---|---|
| Revenue | $2.741B | +6% QoQ |
| EPS | $1.25 | +56% QoQ |
| Gross margin | 37.14% | Reported |
| Operating margin | 10.18% | Reported |
| Free cash flow | $0.092B | -29% QoQ |
| Capex | $0.165B | Reported |
Forward-looking
Forward guidance
| Metric | Period | Range | Midpoint | Status |
|---|---|---|---|---|
| Operating margin | FY2026 | $2.05B–$2.15B | $2.1B | Maintained |
| Revenue | FY2026 | $10.5B–$10.8B | $10.65B | Maintained |
AI, capex & demand read
Management read
Cautiously Optimisti
Management reaffirmed full-year guidance despite acknowledging ongoing macro uncertainty and Middle East conflict, expressing confidence in execution while highlighting challenges ahead.
Investment and capacity
Management mentioned opening a fermentation-based enzyme production site in Argentina and a household care application laboratory in Brazil to support health and biosciences growth in Latin America. CapEx was $165 million year-to-date, roughly 6% of sales.
all 1 named companies below
Companiesreturns since call
Supply chain
ANDURIL
Supply chain
Eric Fehrwald
This is a low-confidence, periphery mention of Anduril based on a likely mis-transcription of 'Arellito' site; no substantive signal about the private company is provided.
Evidence
“In Q1, we also announced regional production and added innovation capabilities to better support the continued strong growth of our health and biosciences business in Latin America.”
External signals
Supply-chain alpha · 4returns since call
Q2 2026 EBITDA is guided to be lower than the $568 million reported in Q1, driven by a temporary slowdown in Middle East fine fragrance volume and customer supply chain challenges (e.g., packaging)
Evidence
“We anticipate that fine fragrance volume in the Middle East will be impacted in the second quarter due to slower market demands, but also temporary supply chain challenges our customers are facing, such as getting packaging into the region.”
IFF is facing double-digit increases in energy and logistics costs immediately, before raw material inflation hits, prompting it to implement pricing surcharges with customers.
Evidence
“We're seeing energy and logistic charges rising, and we haven't really fully implemented our surcharges in place yet, and that will happen over the course of the quarter.”
IFF is explicitly de-emphasizing its 'commodity' fragrance ingredients business (roughly half of its ~$500M annual ingredient sales) due to intense price competition from Indian and Chinese producers.
Evidence
“On the commodity side, that's the part that's very, very challenged and challenged by Indian producers, Chinese producers, and it's an area that we need to continue to have competitive costs for our internal formulation use but we're de-em…”
IFF's food ingredients business sale process is advanced with multiple buyers in second-round due diligence; an update is expected by the Q2 earnings call.
Evidence
“We are running a very disciplined process and it's going very well with several potential buyers going through second round of due diligence and the feedback has been very positive so far.”
Methodology & coverage
Management-only analysis. All 1 validated company mentions are shown. Reported actuals and forward guidance are kept separate. Public evidence is limited to eight short attributed quotes. AI-generated analysis can be incomplete or wrong; verify important claims against the original source.